Israel Englander Aurinia Pharmaceuticals Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Millennium Management LLC holds 11,770 shares of AUPH stock, worth $88,510. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,770

Previous 18,787 37.35%

Holding current value

$88,510

Previous $94,000 28.72%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.81 - $5.78 $33,751 - $40,558	-7,017 Reduced 37.35%	11,770 $67,000
Q1 2024 May 15, 2024	SELL	$4.93 - $9.31 $50,823 - $95,976	-10,309 Reduced 35.43%	18,787 $94,000
Q4 2023 Feb 14, 2024	BUY	$7.13 - $9.49 $88,162 - $117,343	12,365 Added 73.9%	29,096 $261,000
Q2 2023 Aug 14, 2023	SELL	$8.96 - $11.69 $322,963 - $421,366	-36,045 Reduced 68.3%	16,731 $161,000
Q1 2023 May 15, 2023	SELL	$5.94 - $11.27 $355,354 - $674,216	-59,824 Reduced 53.13%	52,776 $578,000
Q4 2022 Feb 14, 2023	BUY	$4.11 - $8.14 $462,786 - $916,564	112,600 New	112,600 $486,000
Q1 2022 May 16, 2022	BUY	$10.05 - $22.48 $3.41 Million - $7.63 Million	339,205 Added 88.48%	722,595 $8.95 Million
Q3 2021 Nov 15, 2021	BUY	$10.93 - $23.55 $4.19 Million - $9.03 Million	383,390 New	383,390 $8.48 Million
Q2 2021 Aug 16, 2021	SELL	$10.0 - $14.52 $635,080 - $922,136	-63,508 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$12.3 - $18.73 $612,552 - $932,772	49,801 Added 363.33%	63,508 $825,000
Q4 2020 Feb 16, 2021	SELL	$12.94 - $16.05 $8.47 Million - $10.5 Million	-654,571 Reduced 97.95%	13,707 $190,000
Q3 2020 Nov 16, 2020	BUY	$13.19 - $16.66 $6.92 Million - $8.74 Million	524,387 Added 364.43%	668,278 $9.84 Million
Q2 2020 Aug 14, 2020	SELL	$14.12 - $18.33 $3.73 Million - $4.84 Million	-264,205 Reduced 64.74%	143,891 $2.34 Million
Q1 2020 May 14, 2020	SELL	$11.34 - $21.46 $17.4 Million - $33 Million	-1,536,998 Reduced 79.02%	408,096 $5.92 Million
Q4 2019 Feb 14, 2020	BUY	$3.88 - $21.42 $5.38 Million - $29.7 Million	1,386,635 Added 248.3%	1,945,094 $39.4 Million
Q3 2019 Nov 14, 2019	BUY	$5.34 - $6.59 $2.71 Million - $3.34 Million	507,053 Added 986.37%	558,459 $2.98 Million
Q2 2019 Aug 14, 2019	SELL	$6.05 - $6.75 $133,208 - $148,621	-22,018 Reduced 29.99%	51,406 $338,000
Q1 2019 May 14, 2019	BUY	$6.06 - $7.64 $444,949 - $560,959	73,424 New	73,424 $477,000
Q1 2018 May 15, 2018	SELL	$4.85 - $5.99 $117,869 - $145,574	-24,303 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$4.53 - $7.09 $69,748 - $109,164	-15,397 Reduced 38.78%	24,303 $110,000
Q3 2017 Nov 14, 2017	BUY	$5.71 - $6.9 $226,687 - $273,930	39,700	39,700 $249,000

Others Institutions Holding AUPH

# of Institutions

190

Shares Held

56.4M

Call Options Held

499K

Put Options Held

637K

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.07B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account